SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-014850
Filing Date
2024-04-16
Accepted
2024-04-16 17:00:38
Documents
48
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 961449
2 ex31-1.htm EX-31.1 17260
3 ex31-2.htm EX-31.2 19584
4 ex32-1.htm EX-32.1 7932
5 ex32-2.htm EX-32.2 7912
6 ex97-1.htm EX-97.1 36144
  Complete submission text file 0001493152-24-014850.txt   4077620

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE tenk-20231231.xsd EX-101.SCH 29740
8 XBRL CALCULATION FILE tenk-20231231_cal.xml EX-101.CAL 28859
9 XBRL DEFINITION FILE tenk-20231231_def.xml EX-101.DEF 172398
10 XBRL LABEL FILE tenk-20231231_lab.xml EX-101.LAB 242976
11 XBRL PRESENTATION FILE tenk-20231231_pre.xml EX-101.PRE 206923
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 431574
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41534 | Film No.: 24848552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)